Scarica l'app Stockscreener
92.27
1.98%
1.79
Pre-mercato:
91.79
-0.48
-0.52%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$90.48
Aprire:
$90.48
Volume 24 ore:
4.17M
Relative Volume:
2.01
Capitalizzazione di mercato:
$20.34B
Reddito:
$7.68B
Utile/perdita netta:
$903.80M
Rapporto P/E:
20.73
EPS:
4.45
Flusso di cassa netto:
$1.14B
1 W Prestazione:
-10.23%
1M Prestazione:
-14.04%
6M Prestazione:
-16.25%
1 anno Prestazione:
-23.47%
Intervallo 1D:
$90.09
$92.91
Intervallo di 1 settimana:
$89.92
$103.27
Portata 52W:
$89.92
$122.25
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Nome
Zimmer Biomet Holdings Inc
Settore
Industria
Telefono
(574) 267-6131
Indirizzo
345 EAST MAIN STREET, WARSAW, IN
Confronta ZBH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
92.27 | 20.34B | 7.68B | 903.80M | 1.14B | 4.45 |
|
ABT
Abbott Laboratories
|
133.06 | 227.05B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.12 | 152.00B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
377.52 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
82.32 | 108.50B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.92 | 44.68B | 5.54B | 4.18B | 259.90M | 7.00 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Peer Perform |
| 2024-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-21 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-08-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-05-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-03-29 | Iniziato | UBS | Sell |
| 2023-03-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Underweight |
| 2022-10-12 | Iniziato | Jefferies | Underperform |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-04-01 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Underperform |
| 2022-03-02 | Downgrade | Loop Capital | Buy → Hold |
| 2022-02-08 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Reiterato | Citigroup | Buy |
| 2022-02-08 | Reiterato | Deutsche Bank | Hold |
| 2022-02-08 | Reiterato | JMP Securities | Mkt Outperform |
| 2022-02-08 | Reiterato | JP Morgan | Neutral |
| 2022-02-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Reiterato | Stifel | Buy |
| 2022-02-08 | Reiterato | Truist | Buy |
| 2022-02-08 | Reiterato | UBS | Neutral |
| 2022-02-08 | Reiterato | Wells Fargo | Underweight |
| 2022-02-02 | Downgrade | UBS | Buy → Neutral |
| 2022-01-19 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Downgrade | Needham | Strong Buy → Buy |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-11-23 | Downgrade | Argus | Buy → Hold |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-09 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Reiterato | Needham | Strong Buy |
| 2020-10-20 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-08-05 | Reiterato | Needham | Strong Buy |
| 2020-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Reiterato | Needham | Strong Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-09-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Aggiornamento | Argus | Hold → Buy |
| 2019-07-30 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Aggiornamento | Needham | Buy → Strong Buy |
Mostra tutto
Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie
Total Wrist Replacement Market Top Companies StudyZimmer - openPR.com
Zimmer Biomet (ZBH) Faces Price Target Reduction Amid Mixed Outlook | ZBH Stock News - GuruFocus
Zimmer biomet updates 2025 guidance with eps range of $7.90-$8.10 amid product launches - MSN
Dental Consumables Market Projected to Hit USD 70.55 Billion by 2032 Amid Rising Demand for Aesthetic and Restorative Dental Care – SNS Insider - GlobeNewswire Inc.
Decoding Zimmer Biomet Holdings Inc (ZBH): A Strategic SWOT Insi - GuruFocus
These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results - Benzinga
Zimmer Biomet Holdings (NYSE:ZBH) Q1 Earnings Rise, Revises 2025 Revenue Guidance Upward - Yahoo Finance
Zimmer Biomet Holdings (ZBH) Price Target Lowered by Stifel Analyst | ZBH Stock News - GuruFocus
Zimmer Biomet Holdings (ZBH) Maintains Outperform Rating Despite Price Target Cut | ZBH Stock News - GuruFocus
Morgan Stanley Adjusts Price Target for Zimmer Biomet Holdings (ZBH) | ZBH Stock News - GuruFocus
Zimmer Biomet stock target cut to $100 by Bernstein SocGen - Investing.com UK
Zimmer Biomet Holdings (ZBH) Receives Target Price Adjustment from JP Morgan | ZBH Stock News - GuruFocus
UBS maintains sell on Zimmer Biomet stock, holds $105 target By Investing.com - Investing.com UK
Zimmer Biomet Holdings (ZBH) Target Price Lowered by Wells Fargo | ZBH Stock News - GuruFocus
Zimmer Biomet (ZBH) Stock Target Lowered as Challenges Weigh In - GuruFocus
Morgan Stanley Reduces Zimmer Biomet (ZBH) Price Target to $95 | - GuruFocus
Zimmer Biomet Holdings (ZBH) Target Price Adjusted by Baird Anal - GuruFocus
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q1 2025 Earnings Call Transcript - Insider Monkey
Zimmer Biomet (ZBH) Target Price Cut by Raymond James Amid Future Tariff Concerns | ZBH Stock News - GuruFocus
Zimmer Biomet (ZBH) Sees Price Target Reduction Amid Q1 Updates - GuruFocus
Zimmer Biomet (ZBH) Price Target Revised by Stifel Analyst | ZBH Stock News - GuruFocus
Zimmer Biomet (ZBH) Faces Price Target Reduction Amid Tariff Con - GuruFocus
Zimmer Biomet flags $60m-$80m tariff impact on 2025 profits - Yahoo Finance
Zimmer Biomet: Stronger Cash Flows Needed Before The Stock Rebounds (NYSE:ZBH) - Seeking Alpha
Zimmer Biomet Q1 2025 net sales increase 1.1% to USD 1.909 bn - Medical Buyer
Zimmer Biomet Holdings First Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Morgan Stanley cuts Zimmer Biomet stock target to $95 By Investing.com - Investing.com India
Zimmer Biomet expects $60M to $80M tariff impact this year - Yahoo Finance
Zimmer Biomet falls 10% after narrowing its 2025 EPS guidance range - MSN
Zimmer Biomet Holdings Inc (ZBH) Q1 2025 Earnings Call Highlights: Navigating Growth Amid ... - Yahoo Finance
Zimmer Biomet Holdings Inc (ZBH) Q1 2025 Earnings Call Highlights: Navigating Growth Amid ... By GuruFocus - Investing.com Canada
Zimmer Biomet Holdings Inc (ZBH) Q1 2025 Earnings Call Highlights: Navigating Growth Amid Tariff Challenges - GuruFocus
Zimmer Biomet's Q1 earnings highlight strategic growth in orthopedic sector - Today's Medical Developments
Zimmer Biomet (ZBH) Shares Plummet 12% on Reduced Earnings Outlook - GuruFocus
Zimmer Biomet Reports Q1 2025 Financial Results - TipRanks
Zimmer: Q1 Earnings Snapshot - MySA
Earnings call transcript: Zimmer Biomet Q1 2025 sees stock fall despite earnings beat - Investing.com Nigeria
Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors - MSN
Zimmer Biomet (ZBH) Faces Price Target Cut Amid Concerns Over Future Growth | ZBH Stock News - GuruFocus
U.S. Indexes Decreased Monday; Zimmer Biomet Holdings Took Biggest Hit - Barron's
Citi cuts Zimmer Biomet stock target to $104, retains neutral stance - Investing.com
Hip Implant Maker Zimmer Biomet Cuts Annual Profit Forecast On Paragon 28 Deal - Benzinga
Zimmer Biomet stock target cut to $102 by Evercore ISI - Investing.com UK
Zimmer Biomet (ZBH) Price Target Reduced by RBC Capital | ZBH Stock News - GuruFocus
Zimmer Biomet (ZBH) Faces Price Target Cut and Mixed Outlook | ZBH Stock News - GuruFocus
Zimmer Biomet Seeks to Accelerate Knee Growth - Morningstar
Citi Adjusts Zimmer Biomet (ZBH) Price Target While Maintaining Neutral Stance | ZBH Stock News - GuruFocus
Zimmer Biomet (ZBH) Sees Growth from Product Launches and Acquisition - GuruFocus
Citigroup Cuts Zimmer Biomet Price Target to $104 From $118 - marketscreener.com
Piper Sandler Cuts Zimmer Biomet Price Target to $100 From $105 - marketscreener.com
Why Zimmer Biomet (ZBH) Stock Is Trading Lower Today - Yahoo Finance
Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
6.05%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):